Such cells include CXCL13+ CD4+ T cells, which have antitumor effects in colon cancer (Ukita et al., 2022), CXCL13+ CD8+ T cells, and CXCL13+ CD8+ proliferating T cells. This evidence concerns the gene CXCL13 and malignant colon neoplasm.